Forebright Capital
Fund focus: Forebright relies on its domain expertise
LP allocations to China funds are limited in number and hotly contested. Forebright Capital closed its latest vehicle by emphasising its track record in advanced manufacturing and enterprise software
Forebright raises $502m for third China fund
China-focused Forebright Capital has closed its third fund with USD 502m in commitments. The manager claimed to have spent about a year in the market.
China: Who’s investing?
Private equity investment in China remains in the doldrums yet local investors claim to see green shoots. Where, when, and how they engage with the market is likely to differ from previous cycles
Southeast Asia, China GPs bullish on exits in 2023
Investors targeting Southeast Asia and China told the Hong Kong Venture Capital & Privat Equity Association's (HKVCA) Asia forum that they were encouraged by liquidity events in 2022 and expect to see more exit opportunities this year.
China mRNA specialist Stemirna gets $200m in funding
Stemirna Therapeutics, which claims to be the first biotech company to bring an mRNA therapeutics and nanomedicine platform to China, has raised $200 million in funding.
Chinese AI player Intellifusion raises $141m
Forebright Capital, Walden International and state-owned Utrust Fund have led a RMB1 billion ($141 million) pre-IPO round for Chinese artificial intelligence (AI) technology developer Intellifusion.
China credit assessment player gets $160m Series D
Chinese financial technology company Wecash has closed a $160 million Series D round led by Orix Asia Capital and Hong Kong-based property investment and development firm SEA Group.
China credit assessment platform Wecash gets $80m
Wecash, a Chinese financial technology company that provides credit evaluations online, has completed an $80 million Series C round jointly led by China Merchants Venture Capital, Forebright Capital and SIG Asia.
China's Jinpan agrees Forebright-backed privatization
Jinpan International, a US-listed Chinese electric transformer manufacturer, has agreed a take-private deal with the company’s chairman and Forebright Capital. It values the business at approximately $98 million.
Forebright supports take-private of China's Jinpan International
Forebright Capital, a PE firm formed last year though a spin-out from China Everbright International, is supporting a $73.9 million take-private bid for US-listed Jinpan International, led by the company’s chairman.